This Article Full Text Full Text (PDF) Other Versions of this Article: IAI.01514-07v1 76/6/2793    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by Chen, Y.-L. Articles by Reynolds, T. B. PubMed PubMed Citation Articles by Chen, Y.-L. Articles by Reynolds, T. B.

 Previous Article  |  Next Article 

Infection and Immunity, June 2008, p. 2793-2801, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01514-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Candida albicans Uses Multiple Mechanisms To Acquire the Essential Metabolite Inositol during Infection

Department of Microbiology, University of Tennessee, Knoxville, Tennessee 37996

Received 14 November 2007/ Returned for modification 19 December 2007/ Accepted 28 January 2008

Candida albicans is an important cause of life-threatening systemic bloodstream infections in immunocompromised patients. In order to cause infections, C. albicans must be able to synthesize the essential metabolite inositol or acquire it from the host. Based on the similarity of C. albicans to Saccharomyces cerevisiae, it was predicted that C. albicans may generate inositol de novo, import it from the environment, or both. The C. albicans inositol synthesis gene INO1 (orf19.7585) and inositol transporter gene ITR1 (orf19.3526) were each disrupted. The ino1/ino1 mutant was an inositol auxotroph, and the itr1/itr1 mutant was unable to import inositol from the medium. Each of these mutants was fully virulent in a mouse model of systemic infection. It was not possible to generate an ino1/ino1 itr1/itr1 double mutant, suggesting that in the absence of these two genes, C. albicans could not acquire inositol and was nonviable. A conditional double mutant was created by replacing the remaining wild-type allele of ITR1 in an ino1/ino1 itr1/ITR1 strain with a conditionally expressed allele of ITR1 driven by the repressible MET3 promoter. The resulting ino1/ino1 itr1/P_MET3::ITR1 strain was found to be nonviable in medium containing methionine and cysteine (which represses the P_MET3 promoter), and it was avirulent in the mouse model of systemic candidiasis. These results suggest a model in which C. albicans has two equally effective mechanisms for obtaining inositol while in the host. It can either generate inositol de novo through Ino1p, or it can import it from the host through Itr1p.

Published ahead of print on 11 February 2008.

Editor: A. Casadevall